MarketCap
Ovid Therapeutics OVID
€ 2.45
14.58%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
130 M |
Marktkapitalisierung |
$ 358 M |
EBITDA (LTM) |
$ -42.2 M |
P/E (LTM) |
- |
P/S (LTM) |
50.264229 |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ММЦБ
GEMA
|
- | - | - | MOEX | Russia |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market |  Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Annexon
ANNX
|
$ 4.33 | 3.34 % | $ 672 M | Nasdaq Global Select Market | USA |
 |
AbbVie
ABBV
|
$ 294.7 | 3.04 % | $ 521 B | NYSE,SPB | USA |
 |
Amgen
AMGN
|
$ 478.61 | 3.76 % | $ 257 B | Nasdaq Global Select Market,SPB | USA |
 |
Theratechnologies
THTX
|
- | - | $ 83.9 M | Nasdaq Capital Market | Canada |
 |
Aldeyra Therapeutics
ALDX
|
$ 0.65 | 4.82 % | $ 39 M | Nasdaq Global Select Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 160.93 | 0.65 % | $ 21.1 B | Nasdaq Global Select Market,SPB | USA |
 |
C4 Therapeutics
CCCC
|
$ 3.12 | -2.96 % | $ 259 M | Nasdaq Global Select Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 0.87 | 0.78 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.36 | -1.36 % | $ 2.83 M | Nasdaq Global Market |  Israel |
 |
Geron Corporation
GERN
|
$ 1.07 | 15.32 % | $ 713 M | Nasdaq Global Select Market | USA |
 |
Titan Pharmaceuticals
TTNP
|
- | -3.76 % | $ 3.47 M | Nasdaq Capital Market | USA |
 |
BioVie
BIVI
|
$ 1.32 | -23.7 % | $ 1.95 M | Nasdaq Capital Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Gossamer Bio
GOSS
|
$ 9.95 | 7.22 % | $ 2.27 B | Nasdaq Global Select Market,SPB | USA |
 |
TCR2 Therapeutics
TCRR
|
- | - | $ 58.1 M | Nasdaq Global Select Market,SPB | USA |
 |
GlaxoSmithKline plc
GSK
|
$ 51.05 | 4.83 % | $ 207 B | NYSE |  Britain |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.42 | -12.65 % | $ 95.5 M | Nasdaq Global Select Market |  Germany |
 |
Immunome
IMNM
|
$ 19.54 | -3.79 % | $ 1.71 B | Nasdaq Global Select Market | USA |
|
Immatics N.V.
IMTX
|
$ 6.9 | -2.47 % | $ 844 M | Nasdaq Global Select Market | Germany |
 |
Incyte Corporation
INCY
|
$ 122.89 | 4.51 % | $ 24 B | Nasdaq Global Select Market,SPB | USA |
 |
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | USA |
 |
Insmed Incorporated
INSM
|
$ 109.95 | 5.28 % | $ 21.9 B | Nasdaq Global Select Market | USA |
 |
Iovance Biotherapeutics
IOVA
|
$ 8.72 | -1.25 % | $ 3.12 M | Nasdaq Global Market,SPB | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.75 | 7.0 % | $ 607 M | Nasdaq Global Select Market | USA |
 |
Jaguar Health
JAGX
|
$ 0.5 | -10.33 % | $ 1.17 M | Nasdaq Capital Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Johnson & Johnson
JNJ
|
$ 276.4 | 3.84 % | $ 665 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.18 | 3.06 % | $ 1.47 M | Nasdaq Global Select Market | USA |
 |
Tyme Technologies
TYME
|
- | 8.07 % | $ 54 M | Nasdaq Capital Market | USA |
 |
Keros Therapeutics
KROS
|
$ 10.89 | 0.55 % | $ 405 M | Nasdaq Global Select Market | USA |
 |
Krystal Biotech
KRYS
|
$ 307.81 | 0.91 % | $ 8.91 B | Nasdaq Global Market,SPB | USA |
 |
Kura Oncology
KURA
|
$ 7.73 | -21.76 % | $ 678 M | Nasdaq Global Select Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 8.08 | -0.25 % | $ 122 M | Nasdaq Global Select Market |  Australia |
 |
Compugen Ltd.
CGEN
|
$ 2.03 | 1.0 % | $ 190 M | Nasdaq Global Market,SPB | Israel |